Beaten-up Nextracker provides investors a reason to believe. But timing is key here

Shares of troubled Nextracker jumped Thursday, the morning after delivering strong quarterly results and increases to the solar company's full-year profitability outlook and project backlog. Revenue in its fiscal 2025 second quarter totaled $635.6 million, up nearly 11% year over year and ahead of the consensus estimate of $615.4...

Read more...

Eli Lilly’s quarter was messy. What to do with the stock is clear-cut

Eli Lilly shares fell Wednesday after the diabetes-and-obesity drug giant posted disappointing third-quarter results and lowered its full-year sales guidance. The report was messy, but it doesn't dim Eli Lilly's bright multiyear outlook, rendering the dip in the stock as a chance to buy. Revenue in the three months...

Read more...

Industrial AI play Dover falls on a noisy quarter. Why we’d buy the dip

Dover on Thursday reported weaker-than-expected third-quarter results, pressuring shares of the industrial conglomerate with ties to AI data centers. We're not concerned: The company's recent asset sales is likely causing some confusion about the numbers. Revenue rose 1.3% year over year to $1.98 billion, a tad shy of the...

Read more...

Abbott Labs shines with a strong quarter and a buyback announcement

Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and upped its earnings guidance for the third straight quarter. Shares rose more than 1%, shaking off an initially subdued reaction. Revenue in the three months ended Sept. 30 rose 4.9% to $10.64 billion, topping estimates of $10.55...

Read more...

Eli Lilly’s blowout quarter should quiet concerns about the stock

Eli Lilly on Thursday reported a home-run quarter fueled by sales of its blockbuster obesity and diabetes drugs, quieting any lingering investor concerns in the stock. Revenue in the second quarter jumped 36% year over year to $11.3 billion, easily topping expectations of $9.92 billion, according to estimates compiled...

Read more...

Disney falls on concerns about its theme parks. Why we’d buy the stock

Shares of Disney fell Wednesday as concerns about attendance at its theme parks overshadowed streaming profits and better-than-expected headline results. However, the quarter checked the boxes that matter most to us, making the stock decline a buying opportunity. Revenue in the fiscal third quarter totaled $23.16 billion, topping the...

Read more...

Linde keeps streak of earnings beats, shows it can handle any economy

Linde on Friday reported another impressive quarter, as the industrial gas supplier continues to demonstrate its reliability and value in a diversified stock portfolio. Revenue in the second quarter totaled $8.27 billion, a bit shy of the $8.32 expected by analysts, according to estimates compiled by LSEG. On annual...

Read more...

Solar stock Nextracker’s strong quarter is eclipsed by backlog concerns

Shares of Nextracker dropped in extended trading Thursday as questions about the solar technology firm's backlog of projects overshadowed its better-than-expected quarterly results. Revenue in its fiscal 2025 first-quarter rose 50% year over year to $719.9 million, far ahead of the $617.5 million expected by analysts, according to LSEG....

Read more...